The influence of primary thyroid cancer to the prognosis of breast cancer: A SEER-based study

Xinyue Chen,Juanjuan Li,Qi Wu,Hanqing Liu,Jingping Yuan,Shengrong Sun
DOI: https://doi.org/10.21203/rs.3.rs-290018/v1
2021-03-15
Abstract:Abstract Purpose: Previous studies have revealed a potential link between breast cancer (BC) and thyroid cancer (TC). This study aimed to estimate the clinical characteristics of BC patients who also had primary TC, and to determine the effect of the sequence of the two malignancies on survival. Methods: We selected female patients with BC or TC in the Surveillance, Epidemiology, and End Results (SEER) database (2000 to 2012), and classified them as four cohorts, BC patients with a second TC (BC2TC cohort), TC patients with a second BC (TC2BC cohort), BC patients without TC (BC cohort) and TC patients without BC (TC cohort). Differences in clinical characteristics were analyzed using the chi-square test. The propensity score matching (PSM) method was performed to balance the baseline characteristics. The survival outcomes were analyzed using the Kaplan-Meier log-rank test. Multivariate Cox regression analyses were used to identify risk factors associated with overall survival (OS) and disease-specific survival (DSS). Results: After PSM, 1,260 pairs of patients with or without second primary TC were included in the survival analysis. The patients in BC2TC cohort had better OS (HR: 0.511(0.421-0.620), P<0.001) and DSS (HR: 0.458(0.346-0.606), P<0.001) than those in BC cohort. The subgroup analysis showed that OS was better in the BC2TC cohort in Luminal A and Luminal B subtypes (P<0.05). Conclusion: We found a second primary TC may improve the prognosis of BC patients, especially in women with Luminal breast cancer, while there was no such trend in TC patients with second BC.
What problem does this paper attempt to address?